5hmC Immunohistochemistry: A Predictor of

5-hydroxymethylcytosine TERT promoter mutation follicular adenocarcinoma immunohistochemistry monoclonal antibodies thyroid neoplasms

Journal

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
ISSN: 1551-5044
Titre abrégé: J Histochem Cytochem
Pays: United States
ID NLM: 9815334

Informations de publication

Date de publication:
08 2023
Historique:
medline: 9 8 2023
pubmed: 24 7 2023
entrez: 24 7 2023
Statut: ppublish

Résumé

Telomerase reverse transcriptase (

Identifiants

pubmed: 37486076
doi: 10.1369/00221554231190437
pmc: PMC10424576
doi:

Substances chimiques

TERT protein, human EC 2.7.7.49
Telomerase EC 2.7.7.49

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

451-458

Références

Endocr Pathol. 2022 Mar;33(1):27-63
pubmed: 35288841
Endocr Pathol. 2020 Dec;31(4):359-366
pubmed: 33058026
Endocr Pathol. 2019 Sep;30(3):246-248
pubmed: 31154561
Exp Ther Med. 2019 Nov;18(5):4002-4010
pubmed: 31641381
Endocr Pathol. 2018 Dec;29(4):380-383
pubmed: 30306386
J Clin Endocrinol Metab. 2014 May;99(5):E754-65
pubmed: 24476079
Endocr Relat Cancer. 2018 Jul;25(7):723-733
pubmed: 29692346
Cell. 2012 Sep 14;150(6):1135-46
pubmed: 22980977
Cancer Cell Int. 2021 Dec 19;21(1):687
pubmed: 34923978
Int J Cancer. 2012 Oct 1;131(7):1577-90
pubmed: 22234893
J Mol Diagn. 2021 Feb;23(2):212-222
pubmed: 33197629
J Clin Pathol. 2021 May 19;:
pubmed: 34011619
Int J Endocrinol. 2022 Jun 15;2022:2658727
pubmed: 35755313
Ann Diagn Pathol. 2022 Apr;57:151903
pubmed: 35121239
Thyroid. 2019 Aug;29(8):1105-1114
pubmed: 31286848
Eur J Cancer. 2019 Feb;108:41-49
pubmed: 30648628
J Clin Endocrinol Metab. 2013 Sep;98(9):E1562-6
pubmed: 23833040
Cancers (Basel). 2019 Sep 26;11(10):
pubmed: 31561592
Curr Oncol. 2021 Sep 28;28(5):3758-3770
pubmed: 34677239
Oncogene. 2014 Oct 16;33(42):4978-84
pubmed: 24141777
J Clin Endocrinol Metab. 2015 Feb;100(2):E243-52
pubmed: 25427145
Oncol Lett. 2019 Sep;18(3):2304-2309
pubmed: 31452729

Auteurs

Martin Hysek (M)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.

Samuel L Hellgren (SL)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.

Vincenzo Condello (V)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

Yiyi Xu (Y)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

Catharina Larsson (C)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.

Jan Zedenius (J)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Breast, Endocrine Tumors, and Sarcoma, Karolinska University Hospital, Stockholm, Sweden.

C Christofer Juhlin (CC)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH